The Correlation for Improvement of Visual Acuity and QOL after Ranibizumab Treatment for Age-Related Macular Degeneration Patients - QUATRO Study

Clinical Research Support Center Kyushu0 sites100 target enrollmentNovember 1, 2013

Overview

No summary available.

Registry

who.int

Start Date

November 1, 2013

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Clinical Research Support Center Kyushu

•1\) Patients whose lesion site evaluated by FA examination is more than 12 optic disc areas (1 optic disc area is 30\.5mm2, a lesion including a bleeding, scar and neo\-vascularization) in subject eye. 2\) Patient with a scar or fibrosis in the range more than 50% of all lesions in subject eye. 3\) Patients with a history of retinal pigment epithelium tear or rupture in subject eye. 4\) Patients with a history of more than stage 3 macular hole in subject eye. 5\) Patients with treatment of triamcinolone intravitreal injection within 6 months in subject eye. 6\) Patient with a history of intraocular surgical operation (including cataract) within 3 months in subject eye. 7\) Patient with a history of surgical operation such as vitrectomy and submacular surgery in subject eye. 8\) Patients with intraocular, extraocular and periocular inflammation or infectious in either eye. 9\) Patients with a history of uveitis in either eye. 10\) Patients with serious allergic history to such as fluoresceine, indocyanine green, iodo. 11\) Women who have pregnancy, possibility of the pregnancy or are nursing. 12\) Any other patients who are regarded as unsuitable for this study by the investigators